Which Obesity Index Best Explains the Link between Adipokines, Coronary Heart Disease Risk and Metabolic Abnormalities in Type 2 Diabetes Mellitus?

Publisher： Karger

E-ISSN： 1423-0151|18|2|123-129

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.18, Iss.2, 2009-02, pp. : 123-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2

By Endler G.   Exner M.   Raith M.   Marculescu R.   Mannhalter C.   Endler L.   Wojta J.   Huber K.   Wagner O.F.  

Thrombosis Research, Vol. 112, Iss. 1, 2003-01 ,pp. : 47-50

Elsevier

Access to resources Recommend Favorite

Cardiovascular Disease Risk of Type 2 Diabetes Mellitus and Metabolic Syndrome: Focus on Aggressive Management of Dyslipidemia

By  

Current Diabetes Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 127-135

Bentham Science Publishers

Access to resources Recommend Favorite

The Risk for Coronary Heart Disease According to Insulin Resistance with and without Type 2 Diabetes

By Kim Jongoh   Chae Young Kwang   Chernoff Arthur  

Endocrine Research, Vol. 38, Iss. 4, 2013-11 ,pp. : 195-205

Informa Healthcare

Access to resources Recommend Favorite

Management of Obesity in Patients with Type 2 Diabetes Mellitus

By  

Current Diabetes Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 95-101

Bentham Science Publishers

Access to resources Recommend Favorite

Managing Type 2 Diabetes Mellitus in Patients with Obesity

By Hauner Hans  

Treatments in Endocrinology, Vol. 3, Iss. 4, 2004-01 ,pp. : 223-232

Adis International

Access to resources Recommend Favorite